Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

29 Sep 2016 07:00

RNS Number : 1267L
Standard Life Euro Pri Eqty Tst PLC
29 September 2016
 

Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2016

 

· NAV rose by 6.2% to 329.3p for the quarter ended 30 June 2016

· Realised gains and income during the quarter ended 30 June 2016 were £13.6 million (2.7% of NAV). The unrealised losses on the portfolio on a constant exchange rate basis were £3.6 million (0.7% of NAV); in addition, there were unrealised foreign exchange gains of £18.8 million (3.7% of NAV)

· 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2016

· NAV total return was 18.2% for the nine months from 1 October 2015 to 30 June 2016. This was after including unrealised foreign exchange gains of £42.8 million (8.4% of NAV)

· Outstanding commitments were £314.3 million at 30 June 2016

· Liquid resources were £109.5 million at 30 June 2016

 

For the quarter ended 30 June 2016 the Company's net asset value per ordinary share ("NAV") rose by 6.2% to 329.3p, from 310.2p at 31 March 2016. At 30 June 2016 the Company's net assets were £509.7 million (31 March 2016 - £480.2 million). NAV total return was 18.2% for the nine months from 1 October 2015 to 30 June 2016.

 

The volume of new buy-out transactions rose modestly in the European private equity market in the second quarter of 2016, while the enterprise value of buy-outs announced increased materially to €27.3 billion, from €15.2 billion in the first quarter of 2016. The material uplift reflected growth in mid-market and particularly large/mega buy-out transactions. The second quarter also witnessed strong mergers and acquisitions activity in Europe and a continuing flow of exits from private equity controlled investments.

 

The closing value of the Company's portfolio of 49 private equity fund interests was £403.7 million at 30 June 2016 (31 March 2016 - £390.6 million). The total unrealised gains on the portfolio for the quarter ended 30 June 2016 were £15.2 million, comprising £3.6 million of unrealised losses on a constant exchange rate basis and £18.8 million of unrealised foreign exchange gains. The MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) fell by 1.8% and rose 3.5% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro and the US dollar appreciating by 4.6% and 7.0% respectively relative to sterling over the quarter.

 

During the quarter ended 30 June 2016 the Company funded £12.3 million of draw downs (six months ended 31 March 2016 - £34.4 million) and received £28.0 million of distributions (six months ended 31 March 2016 - £80.4 million). The distributions received during the quarter generated £13.6 million of realised gains and income, which was equivalent to a return of 2.2 times the acquisition cost of the realised investments. Total draw downs and distributions for the nine months ended 30 June 2016 were £46.7 million and £108.4 million, respectively.

 

The Company made two new fund commitments in the quarter, with a commitment of €28.1 million to Sixth Cinven Fund and €23.0 million to Astorg VI. The Company had total outstanding commitments to its 49 private equity fund interests of £314.3 million at 30 June 2016 (31 March 2016 - £271.5 million). The Manager continues to believe that around £55 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2016 the Company had liquid resources of £109.5 million, comprising a cash balance of £69.0 million and £40.5 million invested at value (£39.4 million at cost) in UK and European equity index tracker funds (31 March 2016 - liquid resources of £94.0 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

 

2. Activity since 30 June 2016

 

On 15 July 2016 the Company paid an interim dividend for the year ended 30 September 2016 of 1.80p per ordinary share.

 

During the period from 1 July to 27 September 2016 the Company funded £17.1 million of draw downs and received £17.6 million of distributions.

 

On 8 July the index tracker funds, having generated income of £1.7 million, were sold generating an overall realised gain of £2.3 million. At 27 September 2016 the Company had cash and money market balances of £106.6 million. The Company also had total outstanding commitments of £307.7 million.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2016 on or around 2 December 2016.

 

 

For further information please contact:-

 

Roger Pim or Peter McKellar at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEVLFLQKFFBBZ
Date   Source Headline
16th Mar 20117:30 amRNSQuarterly Trading Statement
31st Jan 20113:54 pmRNSDirector/PDMR Shareholding
31st Jan 20113:53 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
31st Jan 201111:03 amRNSDirector/PDMR Shareholding
27th Jan 201111:03 amRNSAnnual Financial Report
26th Jan 20119:33 amRNSIssue of Equity
25th Jan 20114:08 pmRNSResult of AGM
25th Jan 20111:00 pmRNSInterim Management Statement
17th Jan 201111:28 amRNSDirector/PDMR Shareholding
6th Jan 20112:05 pmRNSCalculation of Script Dividend Reference Price
6th Jan 201111:28 amRNSQuarterly Disclosure
21st Dec 201011:07 amRNSDoc re. Annual Report
20th Dec 20104:26 pmRNSAnnual Information Update
8th Dec 20104:02 pmRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSPreliminary Results for year to 30/09/10
2nd Dec 20102:30 pmRNSDirectorate Change
30th Nov 20107:00 amRNSRefinancing of debt facility
17th Nov 20109:20 amRNSDirector Declaration
4th Oct 20102:45 pmRNSQuarterly Disclosure
30th Sep 20105:30 pmRNSTotal Voting Rights
28th Sep 201010:46 amRNSApplication for Listing
22nd Sep 20107:00 amRNSInvestment update for quarter to 30 June 2010
10th Aug 201012:49 pmRNSInterim Management Statement
2nd Jun 201012:36 pmRNSHolding(s) in Company
28th May 20107:00 amRNSHalf Yearly Report
9th Apr 201012:46 pmRNSHolding(s) in Company
17th Mar 20107:00 amRNSTrading Statement
9th Feb 201011:40 amRNSDirector/PDMR Shareholding
8th Feb 201010:19 amRNSDirector/PDMR Shareholding
2nd Feb 20103:02 pmRNSDirector/PDMR Shareholding
1st Feb 201011:14 amRNSDirector/PDMR Shareholding
1st Feb 201011:12 amRNSDirector/PDMR Shareholding
1st Feb 201011:10 amRNSDirector/PDMR Shareholding
1st Feb 201011:06 amRNSTotal Voting Rights
27th Jan 20103:39 pmRNSResult of AGM
27th Jan 201012:13 pmRNSInterim Management Statement
27th Jan 201010:00 amRNSApplication for Listing
20th Jan 20109:47 amRNSHolding(s) in Company
14th Jan 201011:30 amRNSAnnual Financial Report
12th Jan 201010:39 amRNSAnnual Information Update
7th Jan 20104:41 pmRNSCalculation of scrip dividend reference price
5th Jan 201012:46 pmRNSQuarterly Disclosure
23rd Dec 200910:57 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20092:25 pmRNSDoc re. Annual Report and Circular
3rd Dec 200912:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSPreliminary results for year to 30/9/09
18th Sep 20097:00 amRNSThird Quarter Trading Statement
29th Jul 20097:30 amRNSInterim Management Statement
8th Jul 20092:23 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.